For the third year in a row, Cooley will sponsor the annual BFC Global Healthcare BD & Investment Conference.
The conference will feature key topics in the following areas:
- Biotech capital market trends in both US and China
- Licensing, the emerging trend among Chinese biotech companies
- Key successful factors for Hong Kong and Nasdaq listing
- Leading biotech company roadshows
Senior executives from more than 500 public & private healthcare companies across the biopharmaceuticals, IVD, medical device and healthcare services sectors attended this event in 2018. More than 300 PE and VC investors from over 100 firms also attended the 2018 conference.
The conference will provide an optimal environment for networking with senior executives of your potential partners. Company management teams and investors will also have the opportunity to participate in one-on-one and small group meetings through BFC Group.
Event details and registration
Featured agenda items
09:15 – 10:15 am: Cross-border Licensing Deal Trend – Perspectives From Leading Biopharma Players
Cooley partners Lila Hope and Christina Zhang will speak.
10:15 – 11:15 am: IPO Markets in US and Hong Kong – Getting the Best of Both Markets
Cooley partners Charlie Kim and Jonie Kondracki will speak.